FeesSafety
Pluang+

BNB Chain's Jenner hard fork adds millisecond timestamps and gas reserve on Chapel testnet

Protocol Fundamentals
23 Oct 2026
Tokenpost
View Source
Neutral
BNB Chain's Jenner hard fork adds millisecond timestamps and gas reserve on Chapel testnet

BNB Chain's Jenner hard fork, activating on the Chapel testnet on Oct 28-29, introduces millisecond-level block timestamps accessible to smart contracts while keeping the existing seconds-based timestamps. It also implements a gas reserve feature, allocating 5% of each block's gas for eligible payment transactions, which can be increased to 10% by governance. Additionally, Jenner lays the groundwork for CAS20, a protocol for compliant assets like stablecoins, though full activation requires further governance steps. This update is mandatory for testnet node operators but has no mainnet activation date yet.

BNB Chain's Jenner testnet upgrade is the subject, with Pluang market data providing context for readers. As of Oct 23, 2026 20:03 WIB, among 50 major cryptocurrencies, 29 rose and 20 fell. BAT rose 4.24% to Rp3.192 with a 66% buy order activity and a typical hold time of 93 days, contrasting with ATOM which fell despite a 90% sell order activity, priced at Rp31.900. BCH also rose 3.46% to Rp5.129.306 with 73% buy orders and a 69-day hold time.

More News

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Zinc and tin supply shortages revive interest in historic US mining districts with new drilling results.

Global zinc supply is expected to fall short by 88,000 tonnes in 2026 amid declining mine production, while tin demand is projected to outpace supply growth through 2035. This has renewed exploration in historic polymetallic mining districts in the U...

Market News
Bullish
44 minutes ago
Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta's AVA6103 shows promise against Enhertu-resistant tumors in early trial and preclinical data

Avacta Therapeutics presented positive preclinical and early clinical data for AVA6103, a novel peptide-drug conjugate targeting FAP-positive tumors resistant to Enhertu. AVA6103 demonstrated superior tumor control and prolonged drug release in precl...

Market News
Bullish
1 hour ago
Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital closes $403.6M CLO deal, pushing total CLO issuance over $2B in under two years.

Obra Capital has closed its fifth Collateralized Loan Obligation (CLO) offering, raising $403.6 million. This deal brings the firm's total CLO issuance to more than $2 billion across five deals in less than two years, demonstrating strong investor co...

Company Fundamentals
Bullish
1 hour ago
Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

Padeliporfin VTP shows promise in making unresectable pancreatic cancer operable in Phase 1 trial

ImPact Biotech reported positive early results from its Phase 1 trial of Padeliporfin VTP in patients with locally advanced, unresectable pancreatic cancer. Of 12 patients treated, 75% have undergone or are scheduled for surgery, with over half achie...

Company Fundamentals
Bullish
1 hour ago
eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware offers a quick diagnostic to help organizations secure sensitive files before Microsoft 365 Copilot rollout.

eSoftware Associates has introduced a free five-minute AI readiness assessment to help regulated organizations identify and prioritize security risks related to sensitive file access in Microsoft 365 before deploying Copilot. The assessment highlight...

Others
Neutral
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App